Genetic Analysis launches GA-map test for infants
This article was originally published in Clinica
Executive Summary
Norwegian molecular diagnostics specialist Genetic Analysis has launched its GA-map test for analysing gut microbes in infants. It is now available worldwide for research use only. GA-map works on the principle that many disorders could be linked to an imbalance in the gut microbial profile, including inflammatory bowel disease, allergy, autism and obesity. The product can process more than 200 samples per day, the Aas-based company claims. GA-map could increase understanding of the causes of disease by highlighting differences in microbial profiles between patients and healthy controls. "Looking ahead, the technology could be used to develop intelligent treatments based on personalised medicine," said the firm's CEO, Dr Morten Isaksen. Genetic Analysis is also developing an adult version of the test.